2007
DOI: 10.1157/13096758
|View full text |Cite
|
Sign up to set email alerts
|

Ceftazidima en infusión continua en el tratamiento de infecciones por Pseudomonas aeruginosa en una Unidad de Hospitalización a Domicilio

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2008
2008
2008
2008

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…The increasing complexity of providing health care has resulted in the development of the HHP which allows for intravenous administration of wide range of antibiotics in the patient’s home. The scientific basis for this new health care modality is supported by the latest pharmacodynamic knowledge regarding different antibiotics (18,19) and the development of new pharmaceutical formulas (20) allowing drug administration in one daily dose or the use of continuous or pulsatile perfusion pumps (21). Furthermore, the widespread use of home‐based antibiotic treatment and the knowledge of its safety in a large variety of infectious diseases (22) have prompted the creation of world reference therapeutic guidelines like those compiled by the American Society of Infectious Diseases (23).…”
Section: Discussionmentioning
confidence: 99%
“…The increasing complexity of providing health care has resulted in the development of the HHP which allows for intravenous administration of wide range of antibiotics in the patient’s home. The scientific basis for this new health care modality is supported by the latest pharmacodynamic knowledge regarding different antibiotics (18,19) and the development of new pharmaceutical formulas (20) allowing drug administration in one daily dose or the use of continuous or pulsatile perfusion pumps (21). Furthermore, the widespread use of home‐based antibiotic treatment and the knowledge of its safety in a large variety of infectious diseases (22) have prompted the creation of world reference therapeutic guidelines like those compiled by the American Society of Infectious Diseases (23).…”
Section: Discussionmentioning
confidence: 99%